Another Nipah outbreak in India: What do we know about

New Post Public Reply Private Reply Replies (0) Message Board
someconcerns
882

Another Nipah outbreak in India: What do we know about this virus and how to stop it?
September 15, 20234:50 PM ET

By

Kamala Thiagarajan

,

Ari Daniel

A field researcher holds a male bat that was trapped in an overhead net as part of an effort to find out how the animals pass Nipah virus to humans. The animal will be tested for the virus, examined and ultimately released.
Fatima Tuj Johora for NPR

The Southern Indian state of Kerala is now battling another deadly outbreak of the Nipah virus, its fourth since 2018. Authorities were alerted to the outbreak after two deaths attributed to the virus. A 49-year-old man named Mohammed Ali, who lived in the village of Maruthonkara, died on August 30, and 40-year-old Mangalatt Haris, who lived in the town of Ayanchery, died on September 11.

On September 13, test results confirmed that both men had died of Nipah. Authorities tested for the virus from routine nose swabs. A combination of flu-like and neurological symptoms — headache, fever, cough, acute respiratory distress and seizures — alerted them to test for the virus.

The virus, first identified among pig farmers in Malaysia in 1999, likely jumped to humans at that time from infected pigs. But there was no human-human transmission noted during the Malaysian outbreaks, says Dr. Thekkumkar Surendran Anish, associate professor for community medicine at the Government Medical College at Manjeri, Kerala, who is leading the state's surveillance team and who spoke to NPR about the situation.

There are two strains of the virus.

"There is virological evidence that the strain we're encountering in Kerala is the Bangladeshi strain," says Anish. This has a high fatality rate of 75% and causes acute respiratory distress, with the higher possibility of human-to-human transmission, he adds.

Meanwhile, health authorities wanted to determine if the cases were related. The one apparent connection, discovered on closed circuit TV footage, is that Haris was visiting a sick relative in a ward in the hospital where Ali was a patient — and the same health worker was identified in both wards. The virus is not airborne but can be spread with contact with body fluids from an infected person or with infected food.

The health worker was not wearing a mask or gloves. "It's possible that he could have transmitted the disease through contact with surfaces such as counters or the side of the bed," Anish says.

On the morning of September 15, Anish encountered yet another case — a 39-year-old man who'd been attending to a patient in the adjacent bed when Mohammed Ali was hospitalized. So far, in addition to the two deaths, Kerala has confirmed six active cases of Nipah.

Kerala has a wide variety of bat species; tests of some fruit bats in 2018 showed that they harbored the virus. Samples of bat urine and half-eaten fruit have now been collected from Maruthonkara, the village in Kozhikode, where the first victim lived, and authorities are testing bats in the area for the virus too.

Health authorities in Kozhikode have created 43 containment zones, especially monitoring anyone with a fever as well as the 950 people who were in contact with the two deceased men. The state's Health Minister Veena George advised the general public to wear masks as a precaution.

"There's no rationale for masking up, since the Nipah virus does not spread through the air," says epidemiologist Raman Kutty, research director at the Amala Cancer Institute in Thrissur, Kerala. "Health authorities are just being very cautious," he says.

They've also asked the public to be vigilant for such symptoms as headache, disorientation, fever, cough and seizures. Neighboring states of Karnataka and Tamil Nadu have been asked to stay on high alert for cases as well.

There is no vaccine nor cure for Nipah yet, and supportive care is all that patients can be given.

"The virus has an incubation period of 14-21 days," says Anish. "Judging from the time of the secondary infections, we're still in the middle of this outbreak," he says. And there's at least one piece of the puzzle that authorities still don't know — How the patient Ali contracted Nipah in the first place.
Editor's note: For more on Nipah, here is an feature we published earlier this year:

It's dusk in central Bangladesh, in a community within the district of Faridpur. A 50-year-old man sits outside his home beside a rice paddy. His name is Khokon. A fiery beard, dyed a bright orange, rings his chin.

He says the procession of disease and death all started in the spring of 2004. "So the first one was the mother-in-law of my elder brother. She was really sick," Khokon says. "She had been sick for some time. Then she died. We took her to the grave. Then my father got sick."

Khokon stares off into the distance as he explains that his father was a spiritual leader in the community. When he became ill, many came to pay their respects and offer their prayers. "Just 12 days after, my father died," he says. "Suddenly, he was no more."

Many of his visitors also got sick. One person traveled to an adjacent village, where four more people fell ill. "It was not understood what was happening," says Mahmudur Rahman, who worked for the Bangladeshi government around that time as director of the Institute of Epidemiology, Disease Control and Research. "Some people who were transporting the patients to the hospital were also getting sick."

Sick often meant encephalitis — a swelling of the brain. Epidemiologist Emily Gurley led an on-site outbreak investigation back then and is now based at Johns Hopkins University. She says, "The signs and symptoms of encephalitis are fever, headache, but often altered mental status or coma." Disorientation and seizures were common. "But many of these patients also had respiratory disease," Gurley adds, which often led to coughing, vomiting and difficulty breathing.

The virus appeared to be spreading through respiratory droplets and saliva. And the sicker people got, the more infectious they became.

For Khokon and his wife, Anwara, the nightmare continued for weeks as they watched relative after relative get sick, suffer and die. Khokon's older brother, his sister, two uncles, his aunt, his nephew and his mom and dad ... all dead. It was numbing. "In Bangla, they say 'it is a bad wind' or 'an act of God,'" explains Rahman.

Anwara says, "When people started dying out of the virus, people were very afraid. No one came here! Nobody, not even a dog came to this house."

And then, the two of them came down with the virus. (Because the disease carries such a stigma, we are using only their first names.) "I actually have no recollection of that time," says Khokon. "I don't even remember who carried me to the hospital or who carried me to the bed. I was in no shape to remember anything. Me and my wife were unconscious. People couldn't say if we were dead or alive."

In addition, Khokon says those caring for them "said that we had high fever, very high fever." Anwara says a neighbor told her, "Like whenever they were touching us, it was like touching fire."

Somehow, they survived. "It was a miracle," says Khokon.

This outbreak, says Rahman, made something brutally evident. The as yet unidentified virus was "obviously showing that we are unable to control it, and it is spreading," he says, from person to person. "That is the clear message."

And with a kill rate of roughly 70%, what virus could be that deadly? At the time, Gurley says, "We didn't know! I was just looking at the data to see what do we think is going on here?"

Gurley wondered, could it be SARS — a coronavirus that infected some 8,000, mainly in China and Hong Kong, from 2002 to 2004?

Or perhaps another, and even more disturbing possibility — could it be a rare, poorly understood virus called Nipah?

"Nipah is terrifying, unusually terrifying," says Dr. Stephen Luby, currently a professor of medicine at Stanford University, who was in charge of the outbreak investigation for eight years at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). He says it's terrifying, in part, because the virus is so deadly in people. Also, the outbreaks are tightly clustered. "And so the people who are sick know each other," he says. "And because of this, it is a clear community crisis."

In addition, part of what makes Nipah so worrisome is that its history offers evidence that it might, under the right conditions, launch a pandemic. It had first shown up in Malaysia and Singapore in the late '90s. Around that time, Malaysia had started farming pork at an industrial scale — huge numbers of pigs wedged into cramped conditions. When the pigs got Nipah from local fruit bats, the virus spread easily. And then, pig farmers caught it as well.

But in Bangladesh, things were different. "There were a few pigs being raised in this village," says Gurley. "None of them had been sick. And none of the cases had had any contact with these pigs. Pretty clearly," she says, pigs didn't seem to be behind these Nipah outbreaks.
A puzzle to solve: How does the virus spill from bats into humans?

A few weeks later, the Centers for Disease Control and Prevention in Atlanta sent an email to Gurley and her colleagues confirming the deadly virus to be Nipah. So they wondered: Just how was the virus spilling over from bats into humans? This was the puzzle that needed solving for two reasons. First, to prevent more people from getting sick. And second, to rein the virus in.

"So what we did is walk through the village and thought about all the possible ways people could come into contact with bats or bat secretions, bat urine, bat saliva," says Gurley.

They thought that maybe it came from climbing trees where the bats had fed or roosted. Or eating fruit off the ground that bats had already taken a bite out of. They considered a much beloved local delicacy: the sap traditionally harvested from date palm trees. "And we thought, 'Well, this would be a great way to have contact with bat secretions because I'm sure the bats love the sap and so do people,'" says Gurley.

The urgency to figure out the connection between bats and humans continued to mount, as Nipah flared again the following year. The investigators came to realize there had also been earlier outbreaks — in 2001 and 2003. Bangladesh decided to set up its own Nipah surveillance system.

Finally, a link emerged, but the researchers needed more evidence. In 2007, they got their chance with yet another outbreak, this time in Thakurgaon in northwest Bangladesh. Of the seven people who contracted Nipah, three were dead. People were again in a panic.

Rebeca Sultana, an anthropologist with the icddr,b, remembers a call to join the investigation team. "Our colleague called me and asked, 'Rebeca, would you like to go? Are you ready?' I said, 'Yes, I am ready to go there.'"

The next morning, Sultana drove with the team from Dhaka to Thakurgaon. Once she arrived in the village, she went straight to the home of patient zero. "I tried to talk to the elder sister-in-law of the guy who died," she says, "and she was so upset and she just ran and came to me, and hugged me and started crying."

Getting that close to her scared Sultana. As Syed Moinuddin Satter, who leads the Emerging Pathogen research group at icddr,b, says, doing this work is like putting "your soul in your hand. You don't know what is waiting for you in the field."

But Sultana's heart went out to the woman. And she hugged her back. She said to her, "Please don't worry. We're here." She explained that although they didn't know for sure what had caused her relatives to fall ill, "we are here to understand why this happened" by listening openly to the people who had witnessed Nipah firsthand.

(At the research center icddr,b, anthropologists are routinely asked to join these kinds of outbreak investigations when trying to piece together routes of transmission. Their job, in Sultana's words, is "to learn from the community." As Sultana's colleague, Shahana Parveen, says, "Our role as anthropologists, when we get into the community, first we give them space to listen to them — their anger, their stress. But we didn't respond, 'OK, this is not right, or this is wrong.'"

After Sultana finished her preliminary interviews, she then asked the community to meet her in the town market to help draw a map of the village. About two dozen people showed up. "I don't do anything," she explains. "I just ask questions. And then they draw it."

Using sticks in the dirt, the residents roughed out houses, roads, bat roosts. The shape of the outbreak gradually emerged. Soon, the villagers began sketching in date palm trees.

"This is the first time the people informed me," Sultana says, of multiple date palm trees and "a sap harvester in this community."

She hadn't seen the date palm trees on the drive in. But staring back at her from the dirt was the possible link between how the fruit bats had passed Nipah into this community. In particular, when the bats drank the sap, the researchers suspected that Nipah could have moved from their saliva or urine into the sap stream, contaminating the sweet liquid. So someone who drank that sap would be in danger of becoming infected.

Sultana and her colleagues tracked down the sap harvester. And he led them to some friends of the guy who was patient zero for this outbreak.

"They said 'we all used to drink raw sap in the morning,'" she says. This was Sultana's aha moment — that patient zero had drunk raw sap before falling ill. She says this helped the researchers trace a line between the bats, the sap and the outbreaks. "It's a long journey," she admits. This journey included work over the next few years where researchers took infrared cameras and caught the bats (among other creatures, including rats, bugs and owls) at night drinking from the same stream of sap that people were harvesting.

Eventually, the government had enough evidence to launch a campaign against the drinking of raw sap. However, it was a lot to ask people to set aside something that had been a cultural practice for hundreds of years. So despite the warnings, people continued to drink the sap.

Ausraful Islam, a veterinarian and infectious disease specialist at the icddr,b, explains that the consumption of raw date palm sap "is not something you can control. You cannot send police to every house, every village to stop them drinking it. It is not possible."

Sultana and her team developed an alternative messaging campaign to promote "safe sap." They helped produce a couple of TV docudramas in which the actors explain how to collect the sap safely — by putting a protective skirt (called a "bana" around the part of the tree with the tap, which keeps the bats out. But people don't always do it. So not every tree is protected. And the spillovers of Nipah virus from bats to people have continued.
Two tricks are the key to Nipah's persistence

It has been 20 years since the harrowing, practically yearly outbreaks started rocking Bangladesh, claiming more than 200 lives to date. And still there's no treatment for Nipah. There's no vaccine. It remains on the World Health Organization's list of viruses with pandemic potential. That's because it has two main tricks.

First, it can jump between species. "We've shown cattle, goats, pigs, cats, dogs can all get infected with Nipah and have been infected with Nipah in Bangladesh," says Gurley. "We don't know how." Perhaps, she says, it's through sap or dropped fruit. Or for pigs and carnivores, it may be through scavenging bat carcasses or placentas. "We're starting a new study to try to figure this out," Gurley says.

The second trick is that Nipah spreads from person to person. So far, Nipah doesn't do a particularly good job of that because the virus tends to kill its host. That means that despite these nearly yearly outbreaks in Bangladesh (with a larger one every four or five years), each has fizzled relatively fast. But each time Nipah makes that leap from bat to person, it gets another chance to find the right combination of mutations to become more transmissible, which could propel it into the realm of a deadly pandemic.

"If we want to contain the virus," says Islam, "we have to understand the virus."

That's why, at 3 a.m. on a cold December morning, Islam stops at the edge of a forest and looks up into the sky, some four stories above the ground, where a 70-foot net stretches between two mahogany trees. He's out here early "because the bats will start coming back from foraging after 3, so this is the best time to catch them," he says.

Early December marks the beginning of what's notoriously known as Nipah season: the four months when the virus is most likely to show up in people. This is when the date palm sap is flowing.

Every month, Islam brings a team out near Faridpur to capture bats. This place is nestled inside the "Nipah Belt," the chunk of central and northwest Bangladesh where — in the words of local physician Dr. Abu Faisal Md Pervez — the virus is synonymous with "death."

The answer isn't getting rid of the bats. Islam has enormous respect for the animals and their importance to the local ecosystem.

Rather, years of studying and sampling thousands of greater Indian fruit bats out here have shown that most of them carry Nipah virus. However, fewer than 1% of them actually release it into the environment. Islam is trying to work out why that is — what's prompting those few animals to shed it.

Most likely, it's connected to some kind of stress the bats are facing. "Is it lack of food?" he wonders. "Is it pregnancy stress? Is it lack of habitat?"

And knowing the answers to those questions could help Islam and his colleagues figure out what action to take to keep Nipah from finding its way into people in the first place.

On and off over the past 15 or so years, Islam and his team have analyzed which strains of the virus are circulating and — in so far small and unconcerning ways — how it's evolving. One of Islam's colleagues, Mohammed Ziaur Rahman, who heads up the One Health Laboratory at icddr,b, says this is the information they need to ultimately conquer the virus. And yet, "we are at the very earliest stages of preparing ourselves to combat Nipah," he confesses.
Nabbing bats and pondering a glass of date sap

The coming dawn is full of sound. Multiple calls to morning prayer from nearby mosques envelop the small research team. Jackals cackle. And birds flute.

Finally, about an hour before daybreak, a female bat is caught in the net. The team brings her down to earth and untangles her with care. She's big — an adult's wingspan easily reaches 3 feet. Her body is brown and furry. The wings are deep black, like a silky, papery fabric. Islam points out her big eyes, like two orbs of amber staring back.

"If it gets the chance," Islam cautions, "it will bite you, like, 10, 15 times. They're very bite-y." To avoid such an outcome, the team has the bat well restrained. The researcher whose hand is in the most vulnerable position has protected himself with a thick glove.

The team finishes untangling the bat and places her in a cotton bag. For now, the bag hangs from a line strung between two trees. It's possible to just make out the contorting and wriggling bat inside.

The researchers nab one more bat, then call it quits. It's getting too light, and any remaining bats will easily spot and avoid the net. They'll transport the animals to a local one-room lab, but not in a van. "Sometimes bats urinate on themselves to mark them," Islam explains. "So if you carry it in the van, the whole van will be stinking."

So they put the bats into a little three-wheeled car and ferry them to the lab some 20 minutes away, where they'll take blood and urine samples. When they're done, they'll release the two bats.

On the drive to the lab, Islam makes a pit stop at a village with a household that's harvesting date palm sap. "It is possible that they will offer you a glass of sap," he remarks to the group. "Please gently deny it, OK?"

When Islam arrives, he walks up to a huge metal tray over a fire. The air is sugary. Gallons of caramel-colored sap are at a rolling boil. It's thickening into molasses.

"It's really sweet," says Muhammad Seraj Khan, the 74-year-old property owner. "It gets sold all around the village. People will buy it to make household sweets and cakes."

The molasses, says Islam, is harmless — any virus gets cooked away. But that's not the case with raw sap. Still, the villagers like to down glasses of the traditional delicacy when they have the chance. And before Islam leaves, Khan offers some of the raw sap.

And there it is — a slightly cloudy liquid. A delicacy and possible poison all at once, because you never know if that invisible menace is lurking within the sweetness.

Ahona Tasnuva served as the interpreter for the reporting team.

Kamala Thiagarajan is a freelance journalist based in Madurai, Southern India. She reports on global health, science, and development, and her work has been published in the New York Times, The British Medical Journal, BBC, The Guardian and other outlets. You can find her on twitter @kamal_t

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CGX Hits Big Stage with New Obstacle Racing Shoes

Updated Category News Views 0

A Bold Step into Obstacle Racing Today, CGX is shaking things up in the world of obstacle racing. The Chinese footwear brand launched its CGX&OCR R1010 and R1020 shoes right at the UIPM 2026 Obstacle World Championships in Beijing. Talk about a grand entrance. Targeting high-stakes international competition, these shoes are set to redefine how athletes tackle those...

Continue Reading
Telit Cinterion Secures U.S. Manufacturing with PA Facility

Updated Category News Views 1

Telit Cinterion Takes a Bold Step in U.S. Manufacturing Here's a move you don't see every day: Telit Cinterion, one of the leading players in the IoT scene, is planting its flag firmly in the good ol' U.S. of A. They're ramping up to start churning out 4G and 5G IoT modules right on American soil by October 2026. This isn't just a small-scale ambition, folks. We're...

Continue Reading
RMX's QuantrusX™: Transforming Edge Intelligence

Updated Category News Views 2

The Edge Gets Real RMX Industries is tearing up the old rulebook of intelligence with their latest move. They’re calling it Real-World Intelligence, and right off the bat, RMX (OTCQB:RMXI) makes it clear they're not here to sell us some dusty data center illusion anymore. They're putting intelligence where the action is, at the physical edge, and that's something you...

Continue Reading
Zum Drivers Shine as New School Year Begins

Updated Category News Views 1

Opening the School Year with High Hopes Zum's crew of enthusiastic drivers hit the streets with a mission: kickstarting the new school year with a sense of excitement that feels fresh, even to a grizzled trader like me. These folks are doing more than just turning the ignition, they’re handling a vital cog in the education machine. From Fresno down to Rockford, you’ll...

Continue Reading
Crunch Fitness Organizes Major 9/11 Tribute Event

Updated Category News Views 2

A Climb for Remembrance In the realm of tributes that hit home, Fitness Ventures might have just nailed one. On this 25th anniversary of September 11, they're pulling no punches by bringing the gritty spirit of NYC right into the heart of 106 Crunch Fitness locations across America. You want to talk about a tribute that resonates, this is it—a Nationwide 9/11...

Continue Reading
Kroger's Strategic Shift: Ibbotson's Bold New Charge

Updated Category News Views 4

Kroger Welcomes a Seasoned Retail Veteran Change often arrives with the dawn of new leadership. As Kroger takes a page from the playbook of large-scale retail transformation, they've enlisted Mark Ibbotson. Effective September 14, Ibbotson will step in as Executive Vice President and Chief Store Operations Officer. It's a roll of the dice that could either accelerate...

Continue Reading
Moore and RMI Forge Alliance for Data-Driven Success

Updated Category News Views 1

RMI and Moore Team Up for Strategic Evolution Let me tell ya, RMI Direct Marketing deciding to join forces with Moore’s AudienceFirst Media is a decision that’ll ripple through the data-driven waters for quite some time. They ain’t merging, mind you, but they’re definitely tying their ships together with a shared compass set on list management and brokerage...

Continue Reading
Nasdaq Flashes Warning Signs for Scage Future's Compliance

Updated Category News Views 2

Two Strikes from Nasdaq: A Wake-Up Call? Scage Future's getting a double-shot of reality from Nasdaq after slipping under crucial thresholds. Here's the score: Scage's been dinged on their Market Value of Listed Securities (MVLS) and Market Value of Publicly Held Shares (MVPHS). Over a stretch from mid-July to late August, these benchmarks floundered below the line. The...

Continue Reading
Leopard Imaging's DragonFire Aims at Industrial Heat Tracking

Updated Category News Views 2

DragonFire: A New Player in Industrial Thermal Imaging Leopard Imaging is strutting onto the thermal imaging stage with a fresh piece of tech—DragonFire. Now, this ain't just another gadget in a long line of gizmos. Unlike your run-of-the-mill cameras, this one packs a punch with its high-resolution uncooled infrared capability. Imagine the kind of precision you can...

Continue Reading
Art Ave Spurs Rebirth in Downtown DC: A Template for Revival

Updated Category News Views 2

Turning Streets into Art Galleries No one would have believed a stretch of DC's bureaucratic offices was about to morph into a vibrant destination worthy of major art aficionados. But here we are, tipping our hats to the Golden Triangle Business Improvement District (BID), who just snagged the IDA Downtown Achievement Award of Excellence for their Art Ave project. Not...

Continue Reading

Top 5 Most Recently Viewed Articles

Blinc Revolutionizes Eye Care with Innovative Peptide Complex

Updated Category News Views 278

Blinc's Eye Repair Peptide Complex Launch Blinc cosmetics, known for their innovative beauty solutions, is making a splash in the eye treatment category with the release of their Eye Repair Peptide Complex. This breakthrough product offers luxury-grade results all while being highly accessible in terms of price. What is the Eye Repair Peptide Complex? The Eye Repair...

Continue Reading
Atossa Therapeutics Showcases (Z)-Endoxifen Research at Conference

Updated Category News Views 80

Atossa Therapeutics Highlights Innovative Cancer Research SEATTLE — Atossa Therapeutics, Inc. (NASDAQ: ATOS), a pioneering clinical-stage biopharmaceutical company, proudly announces its participation at the upcoming American Association for Cancer Research (AACR) Special Conference focused on cancer research. The event takes place from December 9 to 11, featuring a...

Continue Reading
Top Stocks to Consider Before Earnings Reports Approach

Updated Category News Views 305

Navigating the Earnings Season: Strategies for Investors As the earnings season approaches, many investors are preparing for stock movements that can arise from company performances and subsequent evaluations. This dynamic phase not only influences prices but also alters investor sentiments significantly. Investors with experience often realize that pre-reporting periods...

Continue Reading
Graphic Packaging Expands with Eco-Friendly Paperboard

Updated Category News Views 10

Graphic Packaging Launches Eco-Innovative Paperboard Alright, the packaging scene is getting a shake-up, and at the center of it is Graphic Packaging Holding Company jumping feet first into the uncoated recycled paperboard game. Here we go, folks—PaceSetter Ridgeline™, their new 12- to 30-point caliper offering, is rolling out from their Waco, Texas mill, bringing...

Continue Reading
Vesicor Therapeutics and Black Hawk Forge New Biotech Future

Updated Category News Views 188

Transforming Cancer Treatment: A New Business Combination Vesicor Therapeutics, Inc. is taking a pivotal step in the world of biotechnology through a business combination with Black Hawk Acquisition Corporation. This merger aims to enhance the development of p53-based cancer therapeutics delivered via microvesicles. This exciting venture, poised to alter the oncology...

Continue Reading